Citations (79)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Yanli Chen, Dan Tian, Xiaoqi Chen, Zhi Tang, Kuina Li, Zhijiong Huang, Yong Fu, Yanying Feng & Zhijun Yang. (2021) ARRDC3 as a Diagnostic and Prognostic Biomarker for Epithelial Ovarian Cancer Based on Data Mining. International Journal of General Medicine 14, pages 967-981.
Read now
Read now
Signe Sørup, Bianka Darvalics, Azza Ahmed Khalil, Marianne Nordsmark, Mette Hæe, Frede Donskov, Mads Agerbæk, Leo Russo, Dina Oksen, Emmanuelle Boutmy, Patrice Verpillat & Deirdre Cronin-Fenton. (2021) Treatment and Survival in Advanced Non-Small Cell Lung Cancer, Urothelial, Ovarian, Gastric and Kidney Cancer: A Nationwide Comprehensive Evaluation. Clinical Epidemiology 13, pages 871-882.
Read now
Read now
Melanie Campbell & Mohammad Hajizadeh. (2021) Trends in socioeconomic inequalities in the incidence of ovarian cancer among women in Canada: 1992–2010. Women & Health 61:4, pages 381-392.
Read now
Read now
Li Yuan, Qiang An, Ting Liu & Jukun Song. (2021) Classification and clinical value of three immune subtypes of ovarian cancer based on transcriptome data. All Life 14:1, pages 963-975.
Read now
Read now
Shujian Xing, Yaqi Zhang & Jing Zhang. (2020) RETRACTED ARTICLE: LINC01224 Exhibits Cancer-Promoting Activity in Epithelial Ovarian Cancer Through microRNA-485-5p-Mediated PAK4 Upregulation. OncoTargets and Therapy 13, pages 5643-5655.
Read now
Read now
Guan Wang, Huijing Zhang & Peiling Li. (2020) Upregulation of hsa_circRNA_102958 Indicates Poor Prognosis and Promotes Ovarian Cancer Progression Through miR-1205/SH2D3A Axis. Cancer Management and Research 12, pages 4045-4053.
Read now
Read now
Yong Ma, Yiqian Luo, Nan Lin, Yongzhu Lv, Yang Zhou, Bing Li, Kunna Han, Song Jiang & Jianjun Gao. (2018) Prognostic impact of the number of lymph nodes examined in different stages of colorectal mucinous adenocarcinoma. OncoTargets and Therapy 11, pages 3659-3670.
Read now
Read now
Manja Idorn, Maria Olsen, Hólmfrídur Rósa Halldórsdóttir, Signe Koggersbøl Skadborg, Magnus Pedersen, Claus Høgdall, Estrid Høgdall, Özcan Met & Per thor Straten. (2018) Improved migration of tumor ascites lymphocytes to ovarian cancer microenvironment by CXCR2 transduction. OncoImmunology 7:4.
Read now
Read now
Articles from other publishers (71)
Haiyan Zhao, Fangfang Bi, Mengyuan Li, Yuhan Diao & Chen Zhang. (2024) E3 ubiquitin ligase RNF180 impairs IPO4/SOX2 complex stability and inhibits SOX2-mediated malignancy in ovarian cancer. Cellular Signalling 113, pages 110961.
Crossref
Crossref
Akkamahadevi Patil, Sharada Patil, C. E. Anupama, Savitha Rajarajan, Vidya P. Nimbalkar, Usha Amirtham, G. Champaka, M. N. Suma, Geetha V. Patil, Ashwini Nargund, V. R. Pallavi, Linu Jacob, C. S. Premalatha & Jyothi S. Prabhu. (2023)
BRCA1
expression, its correlation with clinicopathological features, and response to neoadjuvant chemotherapy in high‐grade serous ovarian cancer
. Journal of Obstetrics and Gynaecology Research.
Crossref
Crossref
Sofia C. Nunes, Joana Sousa, Fernanda Silva, Margarida Silveira, António Guimarães, Jacinta Serpa, Ana Félix & Luís G. Gonçalves. (2023) Peripheral Blood Serum NMR Metabolomics Is a Powerful Tool to Discriminate Benign and Malignant Ovarian Tumors. Metabolites 13:9, pages 989.
Crossref
Crossref
William Burke, Joel Barkley, Emily Barrows, Rebecca Brooks, Kimberly Gecsi, Kathryn Huber-Keener, Myrlene Jeudy, Shirley Mei, Julia Sage O’Hara & David Chelmow. (2023) Executive Summary of the Ovarian Cancer Evidence Review Conference. Obstetrics & Gynecology 142:1, pages 179-195.
Crossref
Crossref
Xiaokai Wang, Jun Chen, Hongyan Tie, Wei Tian, Yanli Zhao, Luying Qin, Siyan Guo, Qiufang Li & Chen Bao. (2023) Eriodictyol regulated ferroptosis, mitochondrial dysfunction, and cell viability via Nrf2/HO‐1/NQO1 signaling pathway in ovarian cancer cells. Journal of Biochemical and Molecular Toxicology 37:7.
Crossref
Crossref
Zahra Maleki, Mohebat Vali, Hossein-Ali Nikbakht, Soheil Hassanipour, Aida Kouhi, Saman Sedighi, Roya Farokhi & Haleh Ghaem. (2023) Survival rate of ovarian cancer in Asian countries: a systematic review and meta-analysis. BMC Cancer 23:1.
Crossref
Crossref
Houssein El Hajj, Domenico Ferraioli, Pierre Meus, Frederic Beurrier, Olivier Tredan, Isabelle Ray-Coquard & Nicolas Chopin. (2023) Splenectomy in epithelial ovarian cancer surgery. International Journal of Gynecologic Cancer 33:6, pages 944-950.
Crossref
Crossref
Phateep Hankittichai, Phatarawat Thaklaewphan, Nitwara Wikan, Jirapak Ruttanapattanakul, Saranyapin Potikanond, Duncan R. Smith & Wutigri Nimlamool. (2023) Resveratrol Enhances Cytotoxic Effects of Cisplatin by Inducing Cell Cycle Arrest and Apoptosis in Ovarian Adenocarcinoma SKOV-3 Cells through Activating the p38 MAPK and Suppressing AKT. Pharmaceuticals 16:5, pages 755.
Crossref
Crossref
Yuan-Yuan Zheng, Le-Yi Ni, Fei-Fei Ni, Xiao-Qian Wang, Yu-Mei Chen, Min Guo, Xiao-Xia Dong, Qiong-Hui Pan & Cong Chen. (2023) The prediction and treatment of postpartum myofascial pelvic pain. Technology and Health Care 31:2, pages 593-605.
Crossref
Crossref
Paul Schossig, Ebru Coskun, Ruza Arsenic, David Horst, Jalid Sehouli, Eva Bergmann, Nadine Andresen, Christian Sigler, Antonia Busse, Ulrich Keller & Sebastian Ochsenreither. (2023) Target Selection for T-Cell Therapy in Epithelial Ovarian Cancer: Systematic Prioritization of Self-Antigens. International Journal of Molecular Sciences 24:3, pages 2292.
Crossref
Crossref
Tiantian Wang, Yadi Bin, Lanbo Zhao & Qiling Li. (2023) Positive rate of malignant cells in endometrial cytology samples of ovarian cancer, fallopian tube cancer, and primary peritoneal cancer patients: A systematic review and meta-analysis. Journal of Cytology 40:2, pages 51.
Crossref
Crossref
Maria H. Ribeiro & Patricia Lage. 2023. Handbook of Dietary Flavonoids. Handbook of Dietary Flavonoids
1
50
.
Luyang Xiong, Jiahong Tan, Yuchen Feng, Daoqi Wang, Xudong Liu, Yun Feng & Shusheng Li. (2022) Protein expression profiling identifies a prognostic model for ovarian cancer. BMC Women's Health 22:1.
Crossref
Crossref
Ya-Chu Ku, Pin-Han Lin, Chung-Yu Huang, Chia-Wei Lee, Chien-Hung Yu, Shih-Cheng Chen & Wei-Min Liu. (2022) An iminocoumarin based covalent-assembly red-emitting fluorescent probe for detection of β-galactosidase activity in ovarian cancer cells. Dyes and Pigments, pages 111004.
Crossref
Crossref
Li Ning, Jinghe Lang, Bo Long & Lingying Wu. (2022) Diagnostic value of circN4BP2L2 in type I and type II epithelial ovarian cancer. BMC Cancer 22:1.
Crossref
Crossref
Lihui Zhao, Xiaolei Liang, Liyan Wang & Xuehong Zhang. (2022) The Role of miRNA in Ovarian Cancer: an Overview. Reproductive Sciences 29:10, pages 2760-2767.
Crossref
Crossref
Yueyuan Wu, Zhiqun You & Mindan Xu. (2022) Genetic Polymorphism of E2F1 Influences Susceptibility to Ovarian Cancer in a Chinese Population. Contrast Media & Molecular Imaging 2022, pages 1-5.
Crossref
Crossref
Danian Dai, Qiang Li, Pengfei Zhou, Jianjiang Huang, Hongkai Zhuang, Hongmei Wu & Bo Chen. (2022) Analysis of Omics Data Reveals Nucleotide Excision Repair-Related Genes Signature in Highly-Grade Serous Ovarian Cancer to Predict Prognosis. Frontiers in Cell and Developmental Biology 10.
Crossref
Crossref
Cuiping Li, Hongfei Wang, Yulan Chen, Mengshi Fang, Chao Zhu, Yankun Gao, Jianying Li, Jiangning Dong & Xingwang Wu. (2022) A Nomogram Combining MRI Multisequence Radiomics and Clinical Factors for Predicting Recurrence of High-Grade Serous Ovarian Carcinoma. Journal of Oncology 2022, pages 1-13.
Crossref
Crossref
Jing Zhao, Wenxi Tan, Jingying Zheng, Yuanzhen Su & Manhua Cui. (2022) Aptamer Nanomaterials for Ovarian Cancer Target Theranostics. Frontiers in Bioengineering and Biotechnology 10.
Crossref
Crossref
Yali Chen, Ling Han & Ai Zheng. (2022) Association between statin use and the risk, prognosis of gynecologic cancer: A meta-analysis. European Journal of Obstetrics & Gynecology and Reproductive Biology 268, pages 74-81.
Crossref
Crossref
Jinhui Liu, Can Chen, Rui Geng, Fang Shao, Sheng Yang, Zihang Zhong, Senmiao Ni & Jianling Bai. (2022) Pyroptosis-related gene expression patterns and corresponding tumor microenvironment infiltration characterization in ovarian cancer. Computational and Structural Biotechnology Journal 20, pages 5440-5452.
Crossref
Crossref
Faiza Naz, Imran Tariq, Sajid Ali, Ahmed Somaida, Eduard Preis & Udo Bakowsky. (2021) The Role of Long Non-Coding RNAs (lncRNAs) in Female Oriented Cancers. Cancers 13:23, pages 6102.
Crossref
Crossref
Jue Zhu, Lifeng Yan & Qiming Wang. (2021) Efficacy of PD-1/PD-L1 inhibitors in ovarian cancer: a single-arm meta-analysis. Journal of Ovarian Research 14:1.
Crossref
Crossref
Qiancheng Hu, Wenli Kang, Qiuji Wu, Xin Wang, Qingfeng Wang & Ting Luo. (2021) Role of maintenance strategies in advanced epithelial ovarian cancer: a systematic review, network meta-analysis and cost-effectiveness analysis protocol. BMJ Open 11:12, pages e051037.
Crossref
Crossref
Changlei Su & Kejin Huang. (2021) LncRNA TCF7 Promotes Epithelial Ovarian Cancer Viability, Mobility and Stemness via Regulating ITGB8. Frontiers in Oncology 11.
Crossref
Crossref
Min Xie, Qi Fu, Pin-pin Wang & Yu-lan Cui. (2021) STAT1-Induced Upregulation lncRNA LINC00958 Accelerates the Epithelial Ovarian Cancer Tumorigenesis by Regulating Wnt/β-Catenin Signaling. Disease Markers 2021, pages 1-9.
Crossref
Crossref
Haley A. Moss, Jessica A. Perhanidis, Laura J. Havrilesky & Angeles Alvarez Secord. (2021) Real-world treatment patterns of maintenance therapy in platinum-sensitive recurrent ovarian cancer. Gynecologic Oncology 163:1, pages 50-56.
Crossref
Crossref
Qiutong Li, Fang Yang, Xiu Shi, Shimin Bian, Fangrong Shen, Yuhong Wu, Chenjie Zhu, Fengqing Fu, Juan Wang, Jinhua Zhou & Youguo Chen. (2021) MTHFD2 promotes ovarian cancer growth and metastasis via activation of the STAT3 signaling pathway. FEBS Open Bio 11:10, pages 2845-2857.
Crossref
Crossref
Meysam Moghbeli. (2021) MicroRNAs as the critical regulators of Cisplatin resistance in ovarian cancer cells. Journal of Ovarian Research 14:1.
Crossref
Crossref
Ting Luo, Yan Jiang & Jing Yang. (2021) Long Noncoding RNA LINC01554 as a Novel Biomarker for Diagnosis and Prognosis Prediction of Epithelial Ovarian Cancer. Disease Markers 2021, pages 1-5.
Crossref
Crossref
Diana Žilovič, Rūta Čiurlienė, Rasa Sabaliauskaitė & Sonata Jarmalaitė. (2021) Future Screening Prospects for Ovarian Cancer. Cancers 13:15, pages 3840.
Crossref
Crossref
Hao Xu, Yuan Ding & Xiangying Yang. (2021) Overexpression of Long Noncoding RNA H19 Downregulates miR-140-5p and Activates PI3K/AKT Signaling Pathway to Promote Invasion, Migration and Epithelial-Mesenchymal Transition of Ovarian Cancer Cells. BioMed Research International 2021, pages 1-13.
Crossref
Crossref
Maryam Ghanbari-Movahed, Tea Kaceli, Arijit Mondal, Mohammad Hosein Farzaei & Anupam Bishayee. (2021) Recent Advances in Improved Anticancer Efficacies of Camptothecin Nano-Formulations: A Systematic Review. Biomedicines 9:5, pages 480.
Crossref
Crossref
Tamara Jones, Carolina Sandler, Dimitrios Vagenas, Monika Janda, Andreas Obermair & Sandra Hayes. (2021) Physical activity levels among ovarian cancer survivors: a prospective longitudinal cohort study. International Journal of Gynecologic Cancer 31:4, pages 553-561.
Crossref
Crossref
Maryam Ghanbari-Movahed, Gloria Jackson, Mohammad Hosein Farzaei & Anupam Bishayee. (2021) A Systematic Review of the Preventive and Therapeutic Effects of Naringin Against Human Malignancies. Frontiers in Pharmacology 12.
Crossref
Crossref
Mateusz Kozłowski, Katarzyna Nowak & Aneta Cymbaluk-Płoska. (2021) Long-Term Follow-Up of a Female Patient Treated with Olaparib—Hope for a Long Life without Relapse?. International Journal of Environmental Research and Public Health 18:7, pages 3430.
Crossref
Crossref
XiaoYan Zhang, YouMing Sheng, BingWei Li, Qin Wang, XueTing Liu & JianQun Han. (2020) Ovarian cancer derived PKR1 positive exosomes promote angiogenesis by promoting migration and tube formation in vitro. Cell Biochemistry and Function 39:2, pages 308-316.
Crossref
Crossref
Fang Fan, Li Zhang, Xinguang Zhou, Fangya Mu & Guoyue Shi. (2021) A sensitive fluorescent probe for β-galactosidase activity detection and application in ovarian tumor imaging. Journal of Materials Chemistry B 9:1, pages 170-175.
Crossref
Crossref
Izabela Winkler, Justyna Woś, Agnieszka Bojarska-Junak, Andrzej Semczuk, Tomasz Rechberger, Włodzimierz Baranowski, Ewa Markut-Miotła, Jacek Tabarkiewicz, Ewa Wolińska & Maciej Skrzypczak. (2020) An association of iNKT+/CD3+/CD161+ lymphocytes in ovarian cancer tissue with CA125 serum concentration. Immunobiology 225:6, pages 152010.
Crossref
Crossref
Maria Grazia Perrone, Oreste Luisi, Anna De Grassi, Savina Ferorelli, Gennaro Cormio & Antonio Scilimati. (2020) Translational Theragnosis of Ovarian Cancer: where do we stand?. Current Medicinal Chemistry 27:34, pages 5675-5715.
Crossref
Crossref
Hong Zhu, Xia Zou, ShiXin Lin, Xin Hu & Jun Gao. (2020)
Effects of naringin on reversing cisplatin resistance and the Wnt/
β
-catenin pathway in human ovarian cancer SKOV3/CDDP cells
. Journal of International Medical Research 48:10, pages 030006051988786.
Crossref
Crossref
Limei Zheng, Chunyan Cui, Oumin Shi, Xiaoqin Lu, Yuan-kun Li, Wei Wang, Yong Li & Qi Wang. (2020) Incidence and mortality of ovarian cancer at the global, regional, and national levels, 1990–2017. Gynecologic Oncology 159:1, pages 239-247.
Crossref
Crossref
Li Xiao, Zhennan Peng, Anqi Zhu, Renxing Xue, Renming Lu, Jing Mi, Shaowei Xi, Wei Chen & Songshan Jiang. (2020) Inhibition of RUNX1 promotes cisplatin-induced apoptosis in ovarian cancer cells. Biochemical Pharmacology 180, pages 114116.
Crossref
Crossref
Ebrahim Rahmani Moghadam, Hui Li Ang, Sholeh Etehad Asnaf, Amirhossein Zabolian, Hossein Saleki, Mohammad Yavari, Hossein Esmaeili, Ali Zarrabi, Milad Ashrafizadeh & Alan Prem Kumar. (2020) Broad-Spectrum Preclinical Antitumor Activity of Chrysin: Current Trends and Future Perspectives. Biomolecules 10:10, pages 1374.
Crossref
Crossref
Stefano Guadagni, Marco Clementi, Francesco Masedu, Giammaria Fiorentini, Donatella Sarti, Marcello Deraco, Shigeki Kusamura, Ioannis Papasotiriou, Panagiotis Apostolou, Karl Reinhard Aigner, Giuseppe Zavattieri, Antonietta Rossella Farina, Giuseppe Vizzielli, Giovanni Scambia & Andrew Reay Mackay. (2020) A Pilot Study of the Predictive Potential of Chemosensitivity and Gene Expression Assays Using Circulating Tumour Cells from Patients with Recurrent Ovarian Cancer. International Journal of Molecular Sciences 21:13, pages 4813.
Crossref
Crossref
Hai-Bo Zhang, Ying Zeng, Tai-Lin Li & Guo Wang. (2020) Correlation between polymorphisms in IGF2/H19 gene locus and epithelial ovarian cancer risk in Chinese population. Genomics 112:3, pages 2510-2515.
Crossref
Crossref
Zachary Nash & Usha Menon. (2020) Ovarian cancer screening: Current status and future directions. Best Practice & Research Clinical Obstetrics & Gynaecology 65, pages 32-45.
Crossref
Crossref
Mathilde Coustets, Caroline Ladurantie, Elisabeth Bellard, Mélissa Prat, Marie-Pierre Rols, Vincent Ecochard, Gwenaël Ferron, Sophie Chabot, Muriel Golzio & Laurent Paquereau. (2020) Development of a near infrared protein nanoprobe targeting Thomsen-Friedenreich antigen for intraoperative detection of submillimeter nodules in an ovarian peritoneal carcinomatosis mouse model. Biomaterials 241, pages 119908.
Crossref
Crossref
Tianshui Sun & Qing Yang. (2020) Chemoresistance‑associated alternative splicing signatures in serous ovarian cancer. Oncology Letters.
Crossref
Crossref
I. V. Sobolev, R. I. Glushakov, A. E. Protasova, P. D. Shabanov, M. E. Kolpakova & N. I. Tapilskaya. (2020) Hypo- and hyperthyroidism and survival of ovarian cancer patients. Tumors of female reproductive system 15:4, pages 58-65.
Crossref
Crossref
Ji-An Chen, Hongming Pan, Zhijun Wang, Jie Gao, Jiahui Tan, Zhirong Ouyang, Wei Guo & Xianfeng Gu. (2020) Imaging of ovarian cancers using enzyme activatable probes with second near-infrared window emission. Chemical Communications 56:18, pages 2731-2734.
Crossref
Crossref
Kun Ji, Xiaohua Wang, Anqi Zhang & Hongwei Wen. (2020) Prognostic value of microRNA-21 in epithelial ovarian carcinoma. Medicine 99:52, pages e23849.
Crossref
Crossref
Jihye Kim, Young-Jae Cho, Ji-Yoon Ryu, Ilseon Hwang, Hee Dong Han, Hyung Jun Ahn, Woo Young Kim, Hanbyoul Cho, Joon-Yong Chung, Stephen M. Hewitt, Jae-Hoon Kim, Byoung-Gie Kim, Duk-Soo Bae, Chel Hun Choi & Jeong-Won Lee. (2020) CDK7 is a reliable prognostic factor and novel therapeutic target in epithelial ovarian cancer. Gynecologic Oncology 156:1, pages 211-221.
Crossref
Crossref
Luiz Antonio Lupi Júnior, Maira Smaniotto Cucielo, Raquel Fantin Domeniconi, Lucilene Delazari dos Santos, Henrique Spaulonci Silveira, Iseu da Silva Nunes, Marcelo Martinez, Francisco Eduardo Martinez, Wagner José Fávaro & Luiz Gustavo de Almeida Chuffa. (2019) P-MAPA and IL-12 Differentially Regulate Proteins Associated with Ovarian Cancer Progression: A Proteomic Study. ACS Omega 4:26, pages 21761-21777.
Crossref
Crossref
Ruitao Zhang, Huirong Shi, Fang Ren, Wei Feng, Yuan Cao, Gailing Li, Zheying Liu, Pengcheng Ji & Minghui Zhang. (2019) MicroRNA-338-3p suppresses ovarian cancer cells growth and metastasis: implication of Wnt/catenin beta and MEK/ERK signaling pathways. Journal of Experimental & Clinical Cancer Research 38:1.
Crossref
Crossref
Seyed Mostafa Parizadeh, Reza Jafarzadeh-Esfehani, Maryam Ghandehari, Malihe Hasanzadeh, Seyed Mohammad Reza Parizadeh, Seyed Mahdi Hassanian, Afsaneh Rezaei-Kalat, Amirsaeed Sabeti Aghabozorgi, Rana Rahimi-Kakhki, Bita Zargaran, Gordon A Ferns & Amir Avan. (2019) Circulating and Tissue microRNAs as Biomarkers for Ovarian Cancer Prognosis. Current Drug Targets 20:14, pages 1447-1460.
Crossref
Crossref
Said El Shamieh, Fatima Saleh, Shafka Assaad & Fadi Farhat. (2019) Next-generation sequencing reveals mutations in RB1, CDK4 and TP53 that may promote chemo-resistance to palbociclib in ovarian cancer. Drug Metabolism and Personalized Therapy 34:2.
Crossref
Crossref
Tianzhen Wang, Dapeng Hao, Shucai Yang, Jianhui Ma, Weiwei Yang, Yuanyuan Zhu, Mingjiao Weng, Xiang An, Xuefei Wang, Yafei Li, Di Wu, Jing Tang, Chao Yang, Yan He, Lei Zhang, Xiaoming Jin, Guangyu Wang, Zhiwei Li, Tongsen Zheng, Hongxue Meng, Yukuan Feng & Xiaobo Li. (2019) miR-211 facilitates platinum chemosensitivity by blocking the DNA damage response (DDR) in ovarian cancer. Cell Death & Disease 10:7.
Crossref
Crossref
Lei Zhang, Ying Chen, Fangxuan Li, Lewen Bao & Wenxin Liu. (2019) Atezolizumab and Bevacizumab Attenuate Cisplatin Resistant Ovarian Cancer Cells Progression Synergistically via Suppressing Epithelial-Mesenchymal Transition. Frontiers in Immunology 10.
Crossref
Crossref
Frank H. C. Cheng, Hon‐Yi Lin, Tzy‐Wei Hwang, Yin‐Chen Chen, Rui‐Lan Huang, Chia‐Bin Chang, Weiqin Yang, Ru‐Inn Lin, Ching‐Wen Lin, Gary C. W. Chen, Shu‐Yuan Mai, Jora M. J. Lin, Yu‐Ming Chuang, Jian‐Liang Chou, Li‐Wei Kuo, Chin Li, Alfred S. L. Cheng, Hung‐Cheng Lai, Shu‐Fen Wu, Je‐Chiang Tsai & Michael W. Y. Chan. (2019) E2F6 functions as a competing endogenous RNA, and transcriptional repressor, to promote ovarian cancer stemness. Cancer Science 110:3, pages 1085-1095.
Crossref
Crossref
Jinyang Liu, Ting Liu, Lin Liang, Junyu He, Manying Zhang, Yanshan Ge, Shan Liao, Yanhong Zhou & Keqiang Zhang. (2019) Clinical relationships between the rs2212020 and rs189897 polymorphisms of the ITGA9 gene and epithelial ovarian cancer. Journal of Genetics 98:1.
Crossref
Crossref
Yingxia Ning, Weifeng Feng, Xiaocheng Cao, Kaiqun Ren, Meifang Quan, A. Chen, Chang Xu, Yebei Qiu, Jianguo Cao, Xiang Li & Xin Luo. (2019) RETRACTED ARTICLE: Genistein inhibits stemness of SKOV3 cells induced by macrophages co-cultured with ovarian cancer stem-like cells through IL-8/STAT3 axis. Journal of Experimental & Clinical Cancer Research 38:1.
Crossref
Crossref
Qingyuan Su, Qingyuan Lv & Ruijin Wu. (2019) Mining expression and prognosis of FOLR1 in ovarian cancer by using Oncomine and Kaplan-Meier plotter. Pteridines 30:1, pages 158-164.
Crossref
Crossref
Sungsik Kim, Soochi Kim, Jinhyun Kim, Boyun Kim, Se Ik Kim, Min A. Kim, Sunghoon Kwon & Yong Sang Song. (2018) Evaluating Tumor Evolution via Genomic Profiling of Individual Tumor Spheroids in a Malignant Ascites. Scientific Reports 8:1.
Crossref
Crossref
Jie Li, Shu Yao, Kai Wang, Zaijun Lu, Xuantao Su, Li Li, Cunzhong Yuan, Jinbo Feng, Shi Yan, Beihua Kong & Kun Song. (2018) Hypocrellin B‐loaded, folate‐conjugated polymeric micelle for intraperitoneal targeting of ovarian cancer in vitro and in vivo. Cancer Science 109:6, pages 1958-1969.
Crossref
Crossref
S. Banerjee, A.M. Oza, M.J. Birrer, E.P. Hamilton, J. Hasan, A. Leary, K.N. Moore, B. Mackowiak-Matejczyk, J. Pikiel, I. Ray-Coquard, P. Trask, K. Lin, E. Schuth, A. Vaze, Y. Choi, J.C. Marsters, D.J. Maslyar, V. Lemahieu, Y. Wang, E.W. Humke & J.F. Liu. (2018) Anti-NaPi2b antibody–drug conjugate lifastuzumab vedotin (DNIB0600A) compared with pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer in a randomized, open-label, phase II study. Annals of Oncology 29:4, pages 917-923.
Crossref
Crossref
Whasun Lim, Soomin Ryu, Fuller W. Bazer, Sung-Man Kim & Gwonhwa Song. (2018) Chrysin attenuates progression of ovarian cancer cells by regulating signaling cascades and mitochondrial dysfunction. Journal of Cellular Physiology 233:4, pages 3129-3140.
Crossref
Crossref
Wentao Yu, Ran Cui, Hong Qu, Chongdong Liu, Haiteng Deng & Zhenyu Zhang. (2018) Expression and prognostic value of CLIC1 in epithelial ovarian cancer. Experimental and Therapeutic Medicine.
Crossref
Crossref
Hong Zhu, Jun Gao, Lei Wang, Ke‑Jian Qian & Li‑Ping Cai. (2018) In�vitro study on reversal of ovarian cancer cell resistance to cisplatin by naringin via the nuclear factor-κB signaling pathway. Experimental and Therapeutic Medicine.
Crossref
Crossref
Wentao Yu, Hong Qu, Guangming Cao, Chongdong Liu, Haiteng Deng & Zhenyu Zhang. (2017) MtHsp70-CLIC1-pulsed dendritic cells enhance the immune response against ovarian cancer. Biochemical and Biophysical Research Communications 494:1-2, pages 13-19.
Crossref
Crossref